Skip to main content

Table 4 Risk factors for 28-day mortality of candidemia in Shanghai (n=121 episodes)

From: Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai

 

28-day outcome

Mutlivariate analysis

 

Survival (n=87)

Death (n=34)

P value

OR (95% CI)

P value

Gender, male [n(%)]

67 (77.0)

20 (58.8)

0.045

-

0.25

Age (years, Mean±SD)

55.70±20.71

61.38±17.29

0.159

1.038 (1.007-1.069)

0.014

Underlying disease

     

Solid tumor [n(%)]

15 (17.2)

11 (32.4)

0.069

-

0.177

Hematologic malignancy [n(%)]

10 (11.5)

8 (23.5)

0.094

-

0.313

Diabetes mellitus [n(%)]

10 (11.5)

6 (17.6)

0.369

-

-

Cardiac disease [n(%)]

26 (29.9)

6 (17.60

0.17

-

-

Pulmonary disease [n(%)]

17 (19.5)

9 (26.5)

0.404

-

-

Prior surgical intervention (<30 days) [n(%)]

51 (58.6)

15 (44.1)

0.15

-

0.806

Prior antifungal agents use (<30 days) [n(%)]

13 (14.9)

3 (8.8)

0.372

-

-

Corticosteroid use [n(%)]

13 (14.9)

7 (20.6)

0.452

-

-

Severity of clinical feature

     

Sepsis [n(%)]

64 (73.6)

31 (91.2)

0.034

-

0.087

Renal replacement therapy [n(%)]

7 (8.0)

5 (14.7)

0.445

-

-

Parenteral nutrition [n(%)]

34 (39.1)

14 (41.2)

0.832

-

-

Mechanical ventilation [n(%)]

15 (17.2)

7 (20.6)

0.668

-

-

Central venous catheter [n(%)]

68 (78.2)

27 (79.4)

0.88

-

-

Neutropenia [n(%)]

5 (5.7)

9 (26.5)

0.004

17.442 (3.555-85.582)

<0.001

Antifungal therapy within 5 days the first blood culture performed

   

Appropriate empiric therapy

68 (78.2)

18 (52.9)

0.006

0.369 (0.146-0.934)

0.035

Inappropriate empiric therapy

19 (21.8)

16 (47.1)

  Â